Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Roche's GS GType Primer Sets; Illumina's MyGenome; NextBio's NextBio Clinical


Roche has launched its GS GType RUNX1 and GS GType TET2/CBL/KRAS Primer Sets to analyze variations in genes associated with developmental defects, disease progression, and residual disease in a variety of leukemias and myeloid malignancies. The assays were codeveloped with researchers at the MLL Munich Leukemia Laboratory and are designed to be run on Roche's 454 GS FLX and GS Junior systems.

Illumina has launched, MyGenome, an Apple iPad application available for download from the Apple store for 99 cents. The application enables customers to view a demo genome and view reports about important genetic variations.

Illumina plans to eventually launch a version that will allow customers to download information about their own genome when it is sequenced within Illumina's physician-mediated sequencing service (see story, this issue).

NextBio has launched NextBio Clinical, an informatics platform for aggregating and correlating terabyte-scale collections of private and public cross-platform data, data from cell lines, and clinical data from individual patients and population studies.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.